Search - tctmd.com

Displaying 21 - 40 of 91

Sort: Relevancy | Date

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Todd Neale

September 28, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Conference News AHA 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Michael O'Riordan

November 20, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

L.A. McKeown

June 25, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Daily News

FDA Approves Two Generic Versions of Apixaban

Todd Neale

December 23, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

News Daily News

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

Shelley Wood

July 08, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

Advertisement

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Long-term Anticoagulation After Unprovoked VTE: New Insights

One in Five Patients Admitted With COVID-19 Die in the Hospital

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Venous Stents: Long-term Follow-up Plus a New Contender

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

FDA Approves Two Generic Versions of Apixaban

FDA Gives Rivaroxaban Another VTE-Related Indication

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content